This page collects WhisperX intelligence signals tagged #Medical Devices. It is designed for humans, search engines, and AI agents: each item links to a canonical source-backed record with sector, source, timestamp, credibility, and exportable structured data.
The U.S. Food and Drug Administration (FDA) has issued an Early Alert regarding a potential safety issue with certain Impella heart pump devices manufactured by Abiomed. The alert concerns the differential pressure sensor within the devices, which may malfunction. Specifically, the sensor values are reported to potenti...
Fresenius Kabi has initiated a software correction for its Ivenix Large Volume Infusion Pump (LVP) system. The action is being taken in response to identified software anomalies that, if they occur, could lead to serious patient harm or death. The specific nature of the software anomalies was not detailed in the initia...
The U.S. Food and Drug Administration (FDA) has issued an early alert regarding a safety issue with the Impella Generation 1 Purge Cassettes manufactured by Abiomed. The identified problem is an increased risk of purge leaks within the cassette system. These leaks can compromise the device's function by leading to low ...
Johnson & Johnson's MedTech division, operating through its CERENOVUS Inc. subsidiary, has initiated a removal of its CEREPAK Detachable Coil System from the market. The action is being taken in response to a higher-than-expected rate of device failure, specifically a failure of the coil to detach from its delivery sys...
CapsoVision is advancing its next-generation colon capsule technology, targeting a critical FDA 510(k) submission for its Gen 2 Colon capsule and integrated AI module by the third quarter of 2026. This strategic regulatory milestone comes as the company reports accelerating commercial adoption of its current platform, ...
Laser surgical systems maker Lensar is projecting a bold financial target for 2026, forecasting gross margins between 46% and 49%. This forward-looking guidance signals the company's strategic pivot to reignite growth as an independent entity, following the termination of its acquisition deal with industry giant Alcon....
OrthoPediatrics Corp has triggered a significant SEC disclosure, filing an 8-K form that flags the creation of a new direct financial obligation and the entry into a material definitive agreement. The filing, submitted on April 1, 2026, signals a pivotal financial or contractual development for the pediatric orthopedic...
In the crowded field of clinical AI, the coveted FDA 'breakthrough' designation has become a powerful marketing claim and a regulatory fast pass. Since 2016, the Food and Drug Administration has awarded this priority status to over 1,200 medical devices, a significant portion of which are powered by artificial intellig...
Medline Industries, a major medical supply manufacturer, has been formally warned by the U.S. Food and Drug Administration (FDA) over significant quality control failures in its cardiac syringes. The FDA's warning letter, a serious regulatory action, cites specific manufacturing violations that could compromise the saf...
Treace Medical Concepts, Inc. has filed a new 8-K form with the SEC, triggering immediate scrutiny for its inclusion of key sections on executive departures and financial results. The filing, submitted on April 9, 2026, is not a routine update but a structured disclosure covering three critical areas: Item 2.02 for Res...
Retractable Technologies is cutting jobs. The medical device manufacturer is reducing its workforce as part of a strategic move to bolster its domestic production capabilities. This internal restructuring signals a significant operational shift, prioritizing local manufacturing over previous staffing levels. The compa...
Science Corp., the neurotech company co-founded by former Neuralink president Max Hodak, is on the verge of a critical milestone: implanting its first sensor into a human brain. This move signals a direct entry into the high-stakes arena of human brain-computer interfaces, where success could redefine treatment for a r...
Shoulder Innovations, Inc. has triggered a mandatory SEC disclosure, filing an 8-K form to announce its entry into a material definitive agreement. The filing, submitted on April 14, 2026, signals a significant corporate action or contractual commitment that the company is legally obligated to report to investors and t...
The Centers for Medicare and Medicaid Services (CMS) has proposed a significant policy reversal that could choke off a key funding stream for cutting-edge medical devices. The agency aims to repeal a pathway established in 2021 that allowed FDA-designated breakthrough devices to qualify for supplementary Medicare payme...
Stryker has issued a significant update to the use instructions for its patient-fitted TMJ (temporomandibular joint) implants, citing a critical discrepancy in the positioning of a screw hole. This correction, announced via the FDA's MedWatch safety alert system, directly impacts the company's Unilateral and Bilateral ...
The Centers for Medicare & Medicaid Services (CMS) is actively considering terminating a critical payment pathway designed to accelerate patient access to FDA-designated breakthrough medical devices. This potential policy reversal directly threatens a key financial bridge for novel technologies, creating immediate unce...
The Trump administration may be preparing a significant policy move to expand Medicare coverage for so-called 'breakthrough devices,' a signal that could reshape market access for innovative medical technologies. This potential shift, hinted at by officials, suggests a departure from the current, often restrictive, rei...
Milestone Scientific Inc. has filed a significant 8-K form with the SEC, disclosing two material events that signal a shift in its financial and operational posture. The filing, submitted on April 21, 2026, reveals the company has entered into a material definitive agreement and conducted an unregistered sale of equity...
Private equity giants CVC Capital Partners and GTCR are actively exploring a deal to take medical equipment provider Teleflex private. The move signals intense investor interest in the resilient healthcare sector and places one of its established players squarely in the crosshairs of major capital. While discussions ar...
Cochlear Ltd. has triggered a historic market rout, with its shares plummeting the most in over three decades. The Australian hearing implant maker's dramatic stock collapse follows a sudden and significant cut to its full-year profit guidance, signaling a severe and unexpected deviation from its financial trajectory. ...